Continuous-Duration CLL Therapies Patient Perspective
People with CLL shared the following about taking continuous-duration CLL therapies.
“I have been on pirtobrutinib for 7 months. This is my 3rd treatment. Within 2 weeks, my lymph nodes in my neck were not noticeable. I simply take 2 tablets every afternoon. The main side effect is constipation which is managed with MiraLax. I do have some thinning of hair and brittle nails. I will continue on this until it stops working.” -Anonymous CLL patient
A CLL patient named Shelly, who took zanubrutinib, shared the following:
“In my first month, I developed petechia and then mouth sores. After six months, my biggest issue is constipation. I have upped my water and fiber intake daily, and I’m managing much better.”
Do you have additional insights about continuous-duration CLL therapies you would like to share? Click the button below to submit your perspective for us to include in the next version of this guide!
Want to learn more? Click Guide (39/57): Understanding CLL/SLL Treatments: Fixed and Continuous-Duration Therapy Guide